Research & Development

青青草av在线avav在线视频天茂集团连发两公告:吸收合并国华人寿 出清安盛天平


  他們在水槽里嬉鬧,徹底的向所有人努力證明自己還活著。   甦稚露出一嘴細碎的白牙齒笑道︰“我會是最後一個死的人麼?”青青草av   一個粗豪的聲音從牧人群中傳出來︰“這里是我們的牧場,牛是我們的,羊也是我們的,我們不給,該死的馬賊,有膽量就來戰吧!”在线av   李敢見了,重重的一拳砸在木樁子上,對等待已久的親衛們吼道︰“準備出征——”   大鬼巫笑道︰“你今天與右谷蠡王作戰,可曾看出什麼苗頭了沒有?”av在线视频   這是一個很大的題目,放在後世,這絕對是一項需要一個大團體用很長時間才能闡述清楚地問題。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo